First-in-man implantation of the Mitra-Space
Consult the study on "Dynamic transcatheter mitral valve repair: a new concept to treat functional mitral regurgitation using an adjustable spacer" by M. Silaschi, et al.
We report the first-in-man implantation of the Mitra-Spacer. The device was implanted transapically. FMR was reduced to moderate. At two months, while in NYHA Class II, LVEF had improved, but FMR increased and 2 mL was added, reducing FMR to mild. Despite anticoagulation, thrombi developed around the device and the valve was replaced at eight months. The Mitra-Spacer successfully bridged this patient to surgery after LVEF had recovered.